Description: The peptide is used to block Anti-Acinus (pS1180) Antibody (#CPA5535) reactivity. Form: Lyophilized powder Gene Symbol: ACIN1 Alternative Names: ACIN1; ACINUS; KIAA0670; Apoptotic chromatin condensation inducer in the nucleus; Acinus; SCAF4; KIAA1172; SFRS15; Splicing factor arginine/serine-rich 15; CTD-binding SR-like protein RA4; SR-related and CTD-associated factor 4; PNISR; C6orf111; SFRS18; SRRP130; HSPC261; HSPC306; Arginine/serine-rich protein PNISR; PNN-interacting serine/arginine-rich protein; SR-related protein; SR-rich protein; Serine/arginine-rich-splicing regulatory protein 130; SRrp130; Splicing factor arginine/serine-rich 130; Splicing factor arginine/serine-rich 18; RBM39; HCC1; RNPC2; RNA-binding protein 39; Hepatocellular carcinoma protein 1; RNA-binding motif protein 39; RNA-binding region-containing protein 2; Splicing factor HCC1Entrez Gene (Human): 22985; 57466; 25957; 9584Entrez Gene (Mouse) : 56215; 170791SwissProt (Human): Q9UKV3; O95104; Q8TF01; Q14498SwissProt (Mouse) : Q9JIX8; A2AJT4; Q8VH51SwissProt (Rat) : Q63627Purity : >85%Directions for Use : Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4°C for overnight or at room temperature for 2 hours.Quality Control : The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry.Storage/Stability : Shipped at 4°C. Store at -20°C for one year.